Brett Haumann

2020

In 2020, Brett Haumann earned a total compensation of $2.7M as Senior Vice President, Clinical Development and Chief Medical Officer at Theravance Biopharma, a 11% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$213,589
Salary$572,569
Stock Awards$1,903,200
Other$53,267
Total$2,742,625

Haumann received $1.9M in stock awards, accounting for 69% of the total pay in 2020.

Haumann also received $213.6K in non-equity incentive plan, $572.6K in salary and $53.3K in other compensation.

Rankings

In 2020, Brett Haumann's compensation ranked 4,203rd out of 13,090 executives tracked by ExecPay. In other words, Haumann earned more than 67.9% of executives.

ClassificationRankingPercentile
All
4,203
out of 13,090
68th
Division
Manufacturing
1,700
out of 5,621
70th
Major group
Chemicals And Allied Products
657
out of 2,254
71st
Industry group
Drugs
562
out of 1,954
71st
Industry
Pharmaceutical Preparations
428
out of 1,459
71st

Pay ratio

Brett Haumann's Pay$2,742,625
Median Employee's Pay$269,883
Pay Ratio

10

to 1

In 2020, the annual total compensation of Brett Haumann was $2,742,625.

The annual total compensation of the median employee at Theravance Biopharma was $269,883.

The ratio of Brett Haumann's pay to the pay of median employee was therefore 10 to one.

Source: SEC filing on March 22, 2021.

Haumann's colleagues

We found four more compensation records of executives who worked with Brett Haumann at Theravance Biopharma in 2020.

2020

Rick Winningham

Theravance Biopharma

Chief Executive Officer

2020

Vijay Sabesan

Theravance Biopharma

Senior Vice President, Technical Operations

2020

Bradford Shafer

Theravance Biopharma

General Counsel

2020

Andrew Hindman

Theravance Biopharma

Chief Financial Officer

News

You may also like